HDAC6 and pulmonary arterial hypertension: This effect was evidenced by the increased PAH expression observed in the liver of TSA-treated mice and is consistent with previous reports showing that HDAC6 inhibition enhances HSP90 acetylation, which in turn impairs its clearance function and allows stabilization of misfolded client proteins with residual activity27.